- Home
- NVO vs PLTR Comparison
NVO vs PLTR Comparison
Compare NVO & PLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- PLTR
- Stock Information
- Founded
- NVO 1923
- PLTR 2003
- Country
- NVO Denmark
- PLTR United States
- Employees
- NVO N/A
- PLTR N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- PLTR Retail: Computer Software & Peripheral Equipment
- Sector
- NVO Health Care
- PLTR Technology
- Exchange
- NVO Nasdaq
- PLTR Nasdaq
- Market Cap
- NVO 278.0B
- PLTR 274.2B
- IPO Year
- NVO N/A
- PLTR 2020
- Fundamental
- Price
- NVO $65.73
- PLTR $117.30
- Analyst Decision
- NVO Strong Buy
- PLTR Hold
- Analyst Count
- NVO 4
- PLTR 20
- Target Price
- NVO $128.00
- PLTR $88.17
- AVG Volume (30 Days)
- NVO 11.2M
- PLTR 108.1M
- Earning Date
- NVO 05-07-2025
- PLTR 05-05-2025
- Dividend Yield
- NVO 2.45%
- PLTR N/A
- EPS Growth
- NVO 17.93
- PLTR 92.54
- EPS
- NVO 3.40
- PLTR 0.23
- Revenue
- NVO $43,922,211,349.00
- PLTR $3,115,024,000.00
- Revenue This Year
- NVO $20.22
- PLTR $34.11
- Revenue Next Year
- NVO $16.10
- PLTR $28.42
- P/E Ratio
- NVO $19.32
- PLTR $509.27
- Revenue Growth
- NVO 24.11
- PLTR 33.45
- 52 Week Low
- NVO $57.00
- PLTR $20.50
- 52 Week High
- NVO $148.15
- PLTR $125.41
- Technical
- Relative Strength Index (RSI)
- NVO 48.22
- PLTR 60.24
- Support Level
- NVO $64.40
- PLTR $105.32
- Resistance Level
- NVO $69.67
- PLTR $120.38
- Average True Range (ATR)
- NVO 1.74
- PLTR 5.89
- MACD
- NVO 0.85
- PLTR 0.35
- Stochastic Oscillator
- NVO 62.20
- PLTR 76.54
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About PLTR Palantir Technologies Inc.
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.